Skip to main content

Table 2 Summary of FMISO TBRs and FDG TNRs

From: Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas

  FMISO TBR, median (IQR) FDG TNR, median (IQR)
IDH status (n = 87)
Mutant (n = 21) 1.60 (1.49–1.97) 2.17 (1.50–3.45)
Wildtype (n = 66) 2.52 (1.86–3.21) 2.55 (1.97–4.35)
Histology and subtype
AA (n = 18)
 IDH-mut (n = 7) 1.47 (1.42–1.70) 1.50 (1.23–2.55)
 IDH-wt (n = 11) 1.57 (1.46–1.86) 1.90 (1.54–2.39)
AO (n = 11) 1.60 (1.53–1.80) 2.21 (1.83–3.11)
AA + GBM (n = 76)
 IDH-mut (n = 10) 1.70 (1.44–2.21) 1.76 (1.31–3.62)
 IDH-wt (n = 66) 2.52 (1.86–3.21) 2.55 (1.97–4.35)
GBM (n = 58)
 IDH-mut (n = 3) 2.58 (2.27–2.82) 3.80 (2.59–3.95)
 IDH-wt (n = 55) 2.83 (2.24–3.45) 2.73 (2.10–4.41)
  1. IQR interquartile range